Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:ASTNYSE:EOG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASTAsterias Biotherapeutics$0.00$0.00$0.51▼$2.05$111KN/A136,653 shs1,000 shsEOGEOG Resources$111.29-1.4%$112.48$102.52▼$138.18$60.74B0.783.28 million shs1.50 million shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASTAsterias Biotherapeutics0.00%0.00%0.00%0.00%0.00%EOGEOG Resources+1.42%+1.47%+1.77%-7.63%-5.70%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AEOGEOG Resources4.8492 of 5 stars4.33.04.20.22.82.51.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASTAsterias Biotherapeutics 0.00N/AN/AN/AEOGEOG Resources 2.53Moderate Buy$139.5825.42% UpsideCurrent Analyst Ratings BreakdownLatest AST, EOG, DELT, and BLVN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/3/2025EOGEOG ResourcesUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$135.00 ➝ $140.006/2/2025EOGEOG ResourcesBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$137.00 ➝ $140.006/2/2025EOGEOG ResourcesRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetStrong-Buy ➝ Strong-Buy$148.00 ➝ $158.006/2/2025EOGEOG ResourcesMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$132.00 ➝ $135.005/23/2025EOGEOG ResourcesBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$125.00 ➝ $124.005/23/2025EOGEOG ResourcesMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$131.00 ➝ $132.005/20/2025EOGEOG ResourcesRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingStrong-Buy ➝ Strong-Buy5/20/2025EOGEOG ResourcesRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetStrong-Buy ➝ Strong-Buy$140.00 ➝ $148.005/13/2025EOGEOG ResourcesMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$140.00 ➝ $134.005/2/2025EOGEOG ResourcesBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$140.00 ➝ $137.00(Data available from 6/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AN/AEOGEOG Resources$23.39B2.60$14.51 per share7.67$48.17 per share2.31Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASTAsterias BiotherapeuticsN/AN/A0.00∞N/AN/AN/AN/AN/AEOGEOG Resources$7.59B$10.788.969.643.5829.18%23.77%15.24%7/30/2025 (Estimated)Latest AST, EOG, DELT, and BLVN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/1/2025Q1 2025EOGEOG Resources$2.75$2.87+$0.12$2.65$5.92 billion$5.84 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AEOGEOG Resources$3.903.50%+23.07%36.18%8 YearsLatest AST, EOG, DELT, and BLVN DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/2/2025EOGEOG Resourcesquarterly$1.023.7%10/17/202510/17/202510/31/20255/1/2025EOGEOG Resourcesquarterly$0.97503.49%7/17/20257/17/20257/31/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASTAsterias BiotherapeuticsN/AN/AN/AEOGEOG Resources0.132.312.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASTAsterias BiotherapeuticsN/AEOGEOG Resources89.91%Insider OwnershipCompanyInsider OwnershipASTAsterias BiotherapeuticsN/AEOGEOG Resources0.13%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASTAsterias BiotherapeuticsN/A55.66 millionN/ANot OptionableEOGEOG Resources2,850545.79 million560.76 millionOptionableAST, EOG, DELT, and BLVN HeadlinesRecent News About These CompaniesTeamwork Financial Advisors LLC Reduces Stock Position in EOG Resources, Inc. (NYSE:EOG)June 4 at 7:42 AM | marketbeat.comNorthside Capital Management LLC Acquires New Position in EOG Resources, Inc. (NYSE:EOG)June 4 at 7:24 AM | marketbeat.comBarclays Forecasts Strong Price Appreciation for EOG Resources (NYSE:EOG) StockJune 4 at 2:05 AM | americanbankingnews.comEOG Resources, Inc. (NYSE:EOG) Declares Dividend Increase - $1.02 Per ShareJune 3 at 4:53 PM | marketbeat.comUBS Group Boosts EOG Resources (NYSE:EOG) Price Target to $140.00June 3 at 9:21 AM | marketbeat.comUnigestion Holding SA Purchases 40,467 Shares of EOG Resources, Inc. (NYSE:EOG)June 3 at 6:52 AM | marketbeat.comBourgeon Capital Management LLC Acquires 5,234 Shares of EOG Resources, Inc. (NYSE:EOG)June 3 at 6:18 AM | marketbeat.comEOG Resources, Inc. (NYSE:EOG) Shares Sold by Two Sigma Advisers LPJune 3 at 3:56 AM | marketbeat.comRaymond James Forecasts Strong Price Appreciation for EOG Resources (NYSE:EOG) StockJune 3 at 2:11 AM | americanbankingnews.comEOG's Utica Deal Reflects Solid Gas Demand: EQT, AR Stocks to Gain?June 2 at 11:10 AM | zacks.comEOG Resources (NYSE:EOG) Price Target Raised to $140.00 at BarclaysJune 2 at 10:44 AM | marketbeat.comEOG Resources (NYSE:EOG) Stock Price Expected to Rise, Raymond James Analyst SaysJune 2 at 9:31 AM | marketbeat.comEOG Resources (NYSE:EOG) Price Target Raised to $135.00June 2 at 8:57 AM | marketbeat.comEOG Resources to Acquire Encino for $5.6B & Expand in Utica ShaleJune 2 at 8:56 AM | zacks.comEOG Resources (EOG) Sees Price Target Increase Following Acquisition | EOG Stock NewsJune 2 at 8:35 AM | gurufocus.comWright Investors Service Inc. Acquires 3,113 Shares of EOG Resources, Inc. (NYSE:EOG)June 2 at 8:03 AM | marketbeat.comEOG Resources, Inc. (NYSE:EOG) Shares Acquired by American National Bank & TrustJune 2 at 7:54 AM | marketbeat.comEOG Resources, Inc. (NYSE:EOG) Shares Bought by Fragasso Financial Advisors IncJune 2 at 6:35 AM | marketbeat.comEOG Resources, Inc. (NYSE:EOG) Shares Sold by QV Investors Inc.June 2 at 6:35 AM | marketbeat.comEOG Resources’ Strategic Acquisition and Valuation Concerns: Analyst Maintains Hold RatingJune 2 at 6:13 AM | tipranks.comEOG Resources (EOG) Sees Target Price Boost After Strategic Deal | EOG Stock NewsJune 2 at 6:13 AM | gurufocus.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsNVIDIA Stock Surges on Bullish News: How High Could It Climb?By Thomas Hughes | May 13, 2025View NVIDIA Stock Surges on Bullish News: How High Could It Climb?NVIDIA’s AI Robot Leap: 2 Stocks Set to Ride the WaveBy Nathan Reiff | May 23, 2025View NVIDIA’s AI Robot Leap: 2 Stocks Set to Ride the Wave5 Stocks That Crushed Earnings and Guidance ForecastsBy Thomas Hughes | May 8, 2025View 5 Stocks That Crushed Earnings and Guidance ForecastsAnalysts and Institutions Continue to Bet Big on AlphabetBy Ryan Hasson | May 16, 2025View Analysts and Institutions Continue to Bet Big on AlphabetAST, EOG, DELT, and BLVN Company DescriptionsAsterias Biotherapeutics NYSEAMERICAN:AST$0.0020 0.00 (0.00%) As of 07/10/2019Asterias Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing cell-based therapeutics to treat neurological conditions associated with demyelination, and cellular immunotherapies to treat cancer. Its clinical stage programs include AST-OPC1, an oligodendrocyte progenitor cell population derived from pluripotent stem cells that is in Phase I/IIa clinical trial for spinal cord injuries; AST-VAC2 is a non-patient-specific cancer immunotherapy derived from pluripotent stem cells for the treatment of non-small cell lung cancer; and AST-VAC1, a patient-specific cancer immunotherapy that has completed Phase II clinical trial for the treatment of acute myeloid leukemia. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is headquartered in Fremont, California.EOG Resources NYSE:EOG$111.29 -1.53 (-1.36%) As of 01:16 PM EasternEOG Resources, Inc., together with its subsidiaries, explores for, develops, produces, and markets crude oil, natural gas liquids, and natural gas primarily in producing basins in the United States, the Republic of Trinidad and Tobago and internationally. The company was formerly known as Enron Oil & Gas Company. EOG Resources, Inc. was incorporated in 1985 and is headquartered in Houston, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Guidewire Rockets Higher: A Move Above $300 Is Probable TSMC Joins NVIDIA in UAE Push, Fueling Growth Outlook Constellation Energy and Meta Strike Nuclear Deal, Shares Whipsaw Archer's Midnight Air Taxi Soars, But Stock Doesn’t Budge Analog Devices' Cyclical Recovery Story Has Just Begun Microsoft Stock Near Peak, Pullback Seen as Opportunity 3 Reasons Amazon Could Be the Best Tech Performer in June 3 Tech Stocks Insiders Are Buying: Speculative Plays for June Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
